CN104402985B - The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody - Google Patents

The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody Download PDF

Info

Publication number
CN104402985B
CN104402985B CN201410806542.8A CN201410806542A CN104402985B CN 104402985 B CN104402985 B CN 104402985B CN 201410806542 A CN201410806542 A CN 201410806542A CN 104402985 B CN104402985 B CN 104402985B
Authority
CN
China
Prior art keywords
antibody
scaffold molecule
itsn1
antigen
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410806542.8A
Other languages
Chinese (zh)
Other versions
CN104402985A (en
Inventor
马勇杰
应国光
谷峰
付丽
王海龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Medical University Cancer Institute and Hospital
Original Assignee
Tianjin Medical University Cancer Institute and Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Medical University Cancer Institute and Hospital filed Critical Tianjin Medical University Cancer Institute and Hospital
Priority to CN201410806542.8A priority Critical patent/CN104402985B/en
Publication of CN104402985A publication Critical patent/CN104402985A/en
Application granted granted Critical
Publication of CN104402985B publication Critical patent/CN104402985B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a kind of antigen protein of anti-scaffold molecule 1-s antibody and its rabbit polyclonal antibody and purposes, belong to the pharmacy preparation containing antigen or antibody.The sequence of the specific antigen protein of the anti-human scaffold molecule 1-s antibody of the present invention is qpvaissapafgmggias.The specific antigen immune rabbit of anti-human scaffold molecule 1-s antibody is obtained into antiserum, antigenic solution must be prepared after emulsification, the blood containing antibody is collected after injecting adult rabbits, its supernatant, that is, antiserum, the affinity column of TBS buffer solutions balance antigen polypeptide by precooling, addition sodium azide, centrifugal filtration degreasing wash column, and purifying obtains anti-human scaffold molecule 1-s rabbit polyclonal antibodies.The polyclonal antibody is significantly better than with the expression in tissue level on a cellular level utilizes commercialization antibody income effect on sale.It is poor to solve the current anti-human ITSN1-S antibody specificities of commodity on sale, the low problem of potency ratio.

Description

The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody
Technical field
The present invention relates to biomedicine technical field, the antigen protein of specifically a kind of scaffold molecule 1-s antibody and its rabbit Polyclonal antibody and purposes.
Background technology
Scaffold molecule 1(Intersectin1 or ITSN1)It is the albumen being highly conserved during evolution, has in human body Two kinds of spliced bodies of ITSN1-L and ITSN1-S.In central nervous system, ITSN1-L is mainly distributed in neuron, and ITSN1-S is mainly expressed in spongiocyte.Two kinds of spliced bodies possess multiple common protein structure domains.ITSN1-L albumen with A variety of nerve degenerative diseases are related, such as:Mongolism;Alzheimer disease(AD)And Huntington's chorea etc..First The generation of its stupid type get muddled to the ITSN1-L vesicle transports regulated and controled it is related, and the generation of AD and Huntington's chorea with ITSN1-L promotes the neurotoxicity of poly glumine related.ITSN1-S can participate in endocytosis, born of the same parents by its various structures domain It spits, the physiological activities such as cell Proliferation.
Research report about ITSN1-S is less, and for ITSN1-S antibody on sale at present there are poor specificity, potency ratio is low The problem of, it is difficult to it is applied to cellular level and organizes the detection of horizontal ITSN1-S protein.
Polyclonal antibody has the multiple epitopes that can identify same antigen, can be identified in immune detection more anti- It is former, it is not easy to the advantages that influence by antigen conformation variation.Therefore under the same conditions, inspection can be improved using polyclonal antibody The sensitivity of survey, the albumen relatively low to some abundance are easier to detect.
Invention content
The present invention is to solve ITSN1-S antibody on sale at present there are poor specificity, and potency ratio is low, it is difficult to be applied to The problem of cellular level and tissue horizontal ITSN1-S protein detections, and a kind of antigen egg of anti-scaffold molecule 1-s antibody is provided Its rabbit polyclonal antibody of bletilla and purposes.
The present invention is realized according to following technical scheme.
A kind of antigen protein of anti-scaffold molecule 1-s antibody, it is characterised in that:The specific antigen piece of people source ITSN1-S For the amino acid sequence of section as shown in sequence table, the purity of synthesis polypeptide is greater than or equal to 95%.
A kind of antigen protein rabbit polyclonal antibody of anti-scaffold molecule 1-s antibody, it is characterised in that:The polyclonal antibody is Protein immunization segment is carried out using people source ITSN1-S protein sequences, obtains the specific antigen segment for people source ITSN1-S Qpvaissapafgmggias, artificial synthetic polypeptide, and immune adult rabbits, obtain antiserum, prepare antigenic solution, collect supernatant Liquid is antiserum;It is finally purified and is obtained using antigen polypeptide antagonistic Serum;The antibody is in a degree of space structure Upper identification people scaffold molecule 1-s, has the function of the specific recognition to people's scaffold molecule 1-s.
A kind of antigen protein rabbit polyclonal antibody of anti-scaffold molecule 1-s antibody detects anti-human scaffold molecule 1-S preparing Application in protein expression preparation, for expression of the specific detection people scaffold molecule 1-S protein in cell and tissue.
The advantage of the present invention designed in this way is, using anti-ITSN1-S rabbit polyclonals antibody purification obtained by the present invention, Have the function of to fight the specific recognition of scaffold molecule 1-S, i.e., identifies people's scaffold molecule 1-on a degree of space structure S, therefore specific can accurately detect expression of the anti-human scaffold molecule 1-S protein in cell and tissue.On a cellular level It is significantly better than commercial antibody income effect on sale with the expression in tissue level, it is horizontal for more accurate reacting cells With the expression for organizing horizontal ITSN1-S albumen.
Description of the drawings
Fig. 1 be ELISA method of the present invention carry out antibody titer than measurement result compares figure;
Fig. 2 is the glioblastoma cells strain LN-229 cellular levels ITSN1- for expressing exogenous human ITSN1-S albumen The detection figure of S;
Fig. 3 is the glioblastoma cells strain LN- of commercial antibody detection expression exogenous human ITSN1-S albumen on sale The expression figure of ITSN1-S albumen in 229;
Fig. 4 is 200 times of figures of expression of ITSN1-S albumen in present invention detection infiltration ductal carcinoma of breast sample;
Fig. 5 is 400 times of figures of expression of ITSN1-S albumen in present invention detection infiltration ductal carcinoma of breast sample;
Fig. 6 is 200 times of figures of expression of ITSN1-S albumen in present invention detection people's Gene in Infiltrating Lobular Carcinoma of Breast sample;
Fig. 7 is 400 times of figures of expression of ITSN1-S albumen in present invention detection people's Gene in Infiltrating Lobular Carcinoma of Breast sample;
Fig. 8 is 200 times of figures of expression of ITSN1-S albumen in present invention detection people's fibroadenoma of breast sample;
Fig. 9 is 400 times of figures of expression of ITSN1-S albumen in present invention detection people's fibroadenoma of breast sample.
Specific implementation mode
The present invention will be described in detail with reference to the accompanying drawings and embodiments.
One, experiment materials:
People source malignant glioblastoma cell strain LN-229 cell strains are purchased from U.S.'s ATCC cell banks;
Human breast carcinoma tumor clinical samples are tissue-derived in the disease for implementing tumor resection patient in our unit's Breast Surgery Reason stone wax stripping and slicing;
Antigen:Using people source ITSN1-S protein sequences(NM_001001132)The selection for carrying out protein immunization segment, obtains For the specific antigen segment of people source ITSN1-S, qpvaissapafgmggias, artificial synthetic polypeptide, synthesis polypeptide it is pure Degree is greater than or equal to 95%.
Phosphate buffer(PBS):8 grams of sodium chloride, 0.2 gram of potassium chloride, phosphoric acid hydrogen two receive 3.63 grams, potassium dihydrogen phosphate 0.24 gram, it is dissolved in 1 liter of pure water, pH value 7.4.
TBS buffer solutions:The Tris of 10mmol/L contains 0.9%NaCl, with HC1 tune pH to 7.4.
Elution buffer solution:1.5% glycine solution is adjusted to PH1.9 with hydrochloric acid.
Neutralization buffer solution:The Tris-HCl solution of 1M adjusts pH value to 9.0 with concentrated hydrochloric acid.
Two, methods
1. anti-scaffold molecule 1-s(ITSN1-S)The design of the antigen protein sequence of antibody:
Using people source ITSN1-S protein sequences(NM_001001132)Carry out the selection of protein immunization segment.It utilizes The online comparison search tool of Protein Blast protein sequences.It chooses and ITSN1-S protein sequences(NM_001001132)It is similar Strong several variants are compared.Search sequence and its each variant are compared using " multalin " software It is right, find out distinguished sequence, i.e. immune fragment.The distinguished sequence found out is subjected to " protein blast " again, see the sequence with Whether there is specificity between other similar sequences in database.According to the above operation, obtain for the special of people source ITSN1-S Property antigen fragment, qpvaissapafgmggias.
2. according to the immune fragment polypeptide sequence of design, artificial synthetic polypeptide.It is synthesized by Shanghai Gill polypeptide Co., Ltd Polypeptide.Utilize the FMOC strategies of artificial synthetic polypeptide:Using Wang Resin resins, protected amino acid is synthesized, then utilizes contracting Close reagent(HOBT, HBTU, DIEA), cutting reagent(TFA/TIS/H2O)Artificial synthesized desired polypeptides.Using anti-after synthesis Phase HPLC C18 are purified, and the Purity of synthesis is detected using HPLC.The purity of synthesis polypeptide is greater than or equal to 95%。
3. using the polypeptide immune new zealand rabbit of synthesis, antiserum is obtained.With two adult New Zealand rabbits, 100 μ g are closed At polypeptide dissolve in 1ml phosphate buffer solutions, prepare antigenic solution.Mycobacteria is added in freund 's incomplete adjuvant to be made Freund's complete adjuvant, and 1ml antigenic solutions are added, it is fully emulsified.It is subcutaneously injected at 4 different positions when injection, is respectively At back two, two at thigh at.About 500 μ l antigenic solutions of each injection respectively.Per 4-6 weeks injections of antigens, and after injection 7 Blood is collected from rabbit auricular vein within it -10 days.The blood collected before the blood of collection and injection is compared, is checked whether there is Antibody generates.The blood of collection is placed 30 minutes in 37 °C of insulating boxs, then is stood overnight at 4 °C.By blood be transferred to from In heart pipe, 4 °C, 10,000g centrifugations 10 minutes, it is antiserum to collect supernatant.
4. being purified using antigen polypeptide antagonistic Serum, antibody purification is obtained.Prepare the affinity column of antigen polypeptide, utilizes 10 times of affine column volumes and the balance pillar of the TBS buffer solutions by being pre-chilled.Antiserum is placed in 4 °C of refrigerators and is slowly thawed To avoid the aggregation of protein.Solid sodium azide is added to a concentration of 0.05%, 4 °C, 15,000g centrifugations 5 minutes remove clear Clear antiserum is filtered to remove extra fat using filter.By antiserum with TBS buffer solutions with 1:5 ratio carries out dilute It releases, then is filtered with filter.With the speed of 0.5 ml per minute by antiserum on column, to ensure antiserum and filler Combination, need continuous upper prop 2 times and retain efflux.After cleaning pillar with TBS buffer solutions plus the elution buffer of pH2.7 is molten Liquid is eluted to all albumen with the speed of 0.5ml/min and flows down.With having been added to the 1.5 of 100 μ l neutralization buffer solution Ml EP pipes are in charge of collection eluent, check the pH of eluent after mixing with pH test paper, if pH can utilize neutralization buffer less than 7 Liquid is adjusted to about pH7.4 to prevent the denaturation of antibody.10ml is added in column, pH1.9 elution buffer solution is collected as stated above Eluent.Utilize the content of protein in each pipe of spectrophotometric determination.It is preserved at -20 °C after the antibody of purifying is dispensed.
Three, results
1. antibody titer than measurement, Fig. 1 be using ELISA method carry out antibody titer of the present invention than measurement result compare Figure.It is coated with elisa plate with people's scaffold molecule 1-s antigen polypeptides of synthesis, 100 μ l are added per hole, 4 DEG C overnight.Use cleaning solution It washes 3 times, BSA room temperatures is added and close 4 h.After drying, sequentially adding the antibody purification of doubling dilution, (37 DEG C of 30 min, washes 5 It is secondary), 1:10 000 HRP- goat anti-rabbit iggs.Finally plus the colour developing of tmb substrate liquid reads A450 values after termination reaction.Knot Fruit is referring to Fig. 1.Illustrate, using the anti-ITSN1-S rabbit polyclonals antibody purification of present invention gained, to tie in a degree of space People scaffold molecule 1-s is identified on structure, and with the increase of antibody purification concentration, this recognition reaction is stronger.
2. the specificity and sensitivity of application Western Blotting methods antibody purification obtained by cellular level verification.
It is the glioblastoma cells strain LN-229 for utilizing expression exogenous human ITSN1-S albumen referring to Fig. 2, Fig. 2, The detection of ITSN1-S is carried out in cellular level(Western Blotting methods);It is more using anti-human ITSN1-S rabbits obtained by the present invention Clone purification antibody test obtains the molecular weight of albumen that molecular weight is accurately located at after exogenous ITSN1-S and GFP amalgamation and expressions The position of 170KDa instructions, almost without the interference of non-specific band.Absolutely prove that the antibody can be in a degree of space People scaffold molecule 1-s is identified in structure, and being capable of expression of the accurate detection scaffold molecule 1-S protein of specificity in cell.
The glioma cell line of culture, is cracked with cell pyrolysis liquid, and high-temperature denatured at 95 degree, prepares loading sample This.6% polyacrylamide gel is prepared, the vertical gel electrophoresis of the full lysate of cell is carried out.Albumen transfer is carried out after electrophoresis, On protein delivery to nitrocellulose filter.The closing of film is carried out to remove the interference of non-specific factors using 5% milk.Then Present invention gained antibody purification is added(1:1000)It is incubated overnight, secondary antibody uses Goat anti rabbit IRDye 800cw(1:8000)Be incubated 1 hour, the acquisition of result is then carried out by infrared laser imaging device.
Confirm that the antibody has the specificity of confrontation scaffold molecule 1-S, it can be special on a degree of space structure Property identification people's scaffold molecule 1-s.
3. being significantly better than the result of the antibody of commercialization on sale using antibody purification acquired results obtained by the present invention.
Utilize the antibody of commercialization on sale(Santa Cruz, CA, USA)Acquired results are to utilize referring to Fig. 3, Fig. 3 The commercial antibody sold(Antibody goods number sc-9948)The glioblastoma of detection expression exogenous human ITSN1-S albumen The expression of ITSN1-S albumen in cell strain LN-229;(Antibody goods number sc-9948).As a result it shows without specific item Band shows that commercial antibody recognition capability on sale is poor, and poor specificity cannot detect the expression of ITSN1-S albumen.
Using Cell immunohistochemical staining method tissue level on verification the present invention obtained by antibody purification specificity and Sensitivity.Paraffin section is routinely dewaxed using dimethylbenzene after being placed in roasting piece machine baking 2-3h, then carries out graded ethanol Rehydration.Antigen retrieval is carried out using citrate antigen retrieval buffers.Slice is rinsed 3 times with cool clear water, is put into 3% H2O2In tank 10min closes peroxidase.PBS is used after pulling out(Phosphate buffer:8 grams of sodium chloride, 0.2 gram of potassium chloride, phosphoric acid hydrogen two Receive 3.63 grams, 0.24 gram of potassium dihydrogen phosphate is dissolved in 1 liter of pure water, pH value 7.4)Cleaning.It is closed in next step with lowlenthal serum, Then present invention gained antibody is added to be incubated(1:200)It is placed in 4 DEG C of refrigerator overnights.Second day, slice was rinsed 3 times with PBS, Secondary antibody is added(The goat anti-rabbit antibody of HRP labels(1:500), it is placed in room temperature 1h.It is rinsed 3 times with PBS, is directly added into horseradish peroxide Compound enzyme, covered tissue, was put into 37 DEG C of incubators, was incubated 20min.It is rinsed 3 times with PBS, is developed the color using DAB color developing agents. Light brown, developing time ﹤ 10min are showed quickly after DAB liquid is added.PBS is rinsed 3 times after colour developing.Haematoxylin is carried out after DAB colour developings It redyes about 5-10 minutes, is then placed in 1% hydrochloride alcohol, finally returns indigo plant with ammonium hydroxide again.Finally use resin mounting and drying.
4. the protein expression situation that the micro- sem observation present invention is detected.In order to verify the use effect of antibody obtained by the present invention Fruit, we have chosen the tissue samples of 3 mammary gland disease patients, and immunohistochemistry is carried out using antibody purification obtained by the present invention Dyeing.The tissue samples of 3 mammary gland disease patients are invasive ductal carcinoma, invasive lobular carcinoma and mammary gland fibroma respectively.Leaching For lubricant nature duct carcinoma from intraductal carcinoma progress, cancerous tumor cell breaks through conduit basilar memebrane, and interstitial, referred to as Infiltrating ductal are arrived in infiltration Cancer is most common type in breast cancer.Invasive lobular carcinoma is usually developed by lobular carcinoma in situ, and cancerous tumor cell breaks through conduit Interstitial is arrived in basilar memebrane, infiltration, is in that multiple leaflets occur more, is fused to each other to form big tumour with tumour growth, volume is often bright It is aobvious to be more than invasive ductal carcinoma.Mammary gland fibroma, also known as adenofibroma are a kind of connective tissue and epithelial tissue hyperplasia simultaneously, The clear benign tumour of boundary of formation.
The immunohistochemical staining result figure of infiltration ductal carcinoma of breast tissue as an example of Fig. 4 and Fig. 5 is to utilize Gained antibody purification of the invention detects the expression of ITSN1-S albumen in an example infiltration ductal carcinoma of breast tissue, explanation ITSN1-S albumen expliciting the positions are in cytoplasm.The result shows that using the antibody acquired results, without non-specific coloring, fill Bright antibody of defending oneself can identify people scaffold molecule 1-s on a degree of space structure, and being capable of the accurate inspection of specificity Survey the expression of scaffold molecule 1-S protein in the tissue.
Fig. 6 and Fig. 7 is the immunohistochemical staining of an example people's Gene in Infiltrating Lobular Carcinoma of Breast tissue as a result, it is to utilize this Invention gained antibody purification detects the expression of ITSN1-S albumen in an example people's Gene in Infiltrating Lobular Carcinoma of Breast tissue, explanation ITSN1-S albumen expliciting the positions are in cytoplasm.The result shows that using the antibody acquired results, without non-specific coloring, fill Bright antibody of defending oneself can identify people scaffold molecule 1-s on a degree of space structure, and being capable of the accurate inspection of specificity Survey the expression of scaffold molecule 1-S protein in the tissue.
Fig. 8 and Fig. 9 is the immunohistochemical staining result figure of an example human milk adenofibroma patient tissue(Immuning tissue Dyeing SP methods are learned, blue-hematoxylin element is colored as nucleus, and brown DAB painted areas shows the expression of ITSN1-S albumen), It is the expression that ITSN1-S albumen in an example human milk adenofibroma tissue is detected using present invention gained antibody purification, is said Bright ITSN1-S albumen expliciting the position is in cytoplasm.The result shows that using the antibody acquired results, coloured without non-specific, Absolutely prove that the antibody can identify people scaffold molecule 1-s on a degree of space structure, and can be specific accurate Detect the expression of scaffold molecule 1-S protein in the tissue.The above result shows that:In tissue level, resist using obtained by the present invention Body can identify people scaffold molecule 1-s on a degree of space structure, be accurately detected ITSN1-S albumen in various mammary gland Expliciting the position in diseased tissue and expression.
In conclusion the result of Fig. 1-9 absolutely proves the antigen protein using the anti-scaffold molecule 1-s antibody of present invention gained Rabbit polyclonal antibody, it is horizontal on cellular level in tissue, people's bridge point can be identified on a degree of space structure Sub- 1-s, for accurately detecting expliciting the position and expression of the ITSN1-S albumen in cell and tissue.
SEQUENCE LISTING
<110>Tumour hospital of Medical University Of Tianjin
<120>The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody
<130> protein
<160> 1
<170> PatentIn version 3.3
<210> 1
<211> 18
<212> PRT
<213> 2 Ambystoma laterale x Ambystoma jeffersonianum
<220>
<221> protein
<222> (1)..(18)
<400> 1
Gln Pro Val Ala Ile Ser Ser Ala Pro Ala Phe Gly Met Gly Gly Ile
1 5 10 15
Ala Ser

Claims (3)

1. a kind of antigen protein preparing anti-scaffold molecule 1-s antibody, it is characterised in that:The specificity of people source ITSN1-S The amino acid sequence of antigen fragment such as SEQ ID NO:Shown in 1, the purity of synthesis polypeptide is greater than or equal to 95%.
2. a kind of rabbit polyclonal prepared by the antigen protein for preparing anti-scaffold molecule 1-s antibody as described in claim 1 Antibody, it is characterised in that:Using the specific antigen segment artificial synthetic polypeptide of the people source ITSN1-S, and it is immunized into Year rabbit obtains antiserum, prepares antibody-solutions, and it is antiserum to collect supernatant;Finally apply antigen polypeptide antagonistic Serum into Row is purified and is obtained.
3. a kind of rabbit polyclonal prepared by the antigen protein for preparing anti-scaffold molecule 1-s antibody as claimed in claim 2 is anti- Body is preparing the application in detecting anti-human scaffold molecule 1-S protein expression preparation, is used for specific detection people's scaffold molecule 1-S Expression of the albumen in cell and tissue.
CN201410806542.8A 2014-12-23 2014-12-23 The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody Active CN104402985B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410806542.8A CN104402985B (en) 2014-12-23 2014-12-23 The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410806542.8A CN104402985B (en) 2014-12-23 2014-12-23 The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody

Publications (2)

Publication Number Publication Date
CN104402985A CN104402985A (en) 2015-03-11
CN104402985B true CN104402985B (en) 2018-10-26

Family

ID=52640663

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410806542.8A Active CN104402985B (en) 2014-12-23 2014-12-23 The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody

Country Status (1)

Country Link
CN (1) CN104402985B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108864255B (en) * 2018-06-21 2022-01-04 天津医科大学肿瘤医院 Breast cancer stem cell specific binding polypeptide and application thereof in preparation of medicine for treating breast cancer
CN113121683B (en) * 2021-04-14 2022-01-14 南通大学 Preparation method of cotton GraiRGA transcription factor specific recognition antibody

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GenBank:NP_001001132.1;Russo,A等;《GenBank》;20130608;全文 *
ITSN1-S的SH3功能域对恶性胶质瘤细胞U87增殖能力的影响;王丽等;《中国肿瘤临床》;20130930;第40卷(第18期);第1089-1093页 *
人ITSN2基因新剪接异构体的克隆和鉴定;刘倩;《湖南师范大学论文集》;20120315;第23页最后1段-第24页第1段,第25页最后1段至第26页第5段,摘要 *

Also Published As

Publication number Publication date
CN104402985A (en) 2015-03-11

Similar Documents

Publication Publication Date Title
CN104662044B (en) For treating ROR1 cancers and inhibiting the antibody and vaccine that shift
CN102639564B (en) Anti-CMET antibody and its use for the detection and the diagnosis of cancer
CN103718045B (en) The detection method of pancreas cancer
CN110144009A (en) CD47 single domain antibody and application thereof
CN109096395A (en) Blocking-up type CD47 nano antibody and application thereof
CN106581694A (en) Genetic products differentially expressed in tumors and the use thereof
CN109071675A (en) Using the antibodies for treating cancer of advanced glycation final product (AGE), kills metastatic carcinoma cell and prevent the method and composition of cancer metastasis
KR102235380B1 (en) Method for detecting pancreatic tumor, antibodies, and kit for the detection of pancreatic tumor
CN105814079A (en) Antibodies and assays for detection of folate receptor 1
CN103298836B (en) For obtaining the preparation method of the antigen of anti-hydrophobic peptide antibody
CN105026422B (en) SH2 domain variants
CN107022029A (en) The monoclonal antibody of highly-specific highly Sensitive Detection alpha-fetoprotein and kit and application
CN107022030A (en) Detect monoclonal antibody and kit and the application of alpha-fetoprotein
CN108135933A (en) Protein 2 and cancer containing motile sperm structural domain
CN106146664A (en) Antibody and Fab thereof for kidney related antigen 1
CN101679485A (en) Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
CN104402985B (en) The antigen protein and its rabbit polyclonal antibody and purposes of anti-scaffold molecule 1-s antibody
CN107298697B (en) Human PD-L1 protein Y123Site phosphorylation antibody and preparation method and application thereof
CN108840920A (en) A kind of human CYR 61 Protein S er167 site phosphorylation antigen, antibody and its preparation method and application
Yuan et al. Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy
CN103694332B (en) A kind of new tumor markers
CN103923212A (en) EHD2 antibody and application of EHD2 antibody to preparation of immunohistochemical detection reagent for breast cancer
CN108752454A (en) A kind of human CYR 61 Protein S er188 site phosphorylations antigen, antibody and its preparation method and application
CN107690439A (en) IGF 1R antibody and its purposes for diagnosing cancer
CN110183530A (en) Leptin immunogene, hybridoma, monoclonal antibody, polyclonal antibody and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant